Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Guardant Health, Inc.GH · Entity 3238 | Chief People Officer | October 01, 2026 | October 03, 2026 |
| LiveRamp Holdings, Inc.ACXM · Entity 4412 | Chief People & Culture Officer | September 14, 2017 | September 15, 2017 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Guardant Health, Inc.
Report date October 01, 2026 · Filed October 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 24,900 |
Ending reported balance
After 2026-10-01 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2026-10-01 · Exercise / conversion · Acquired 2,659 · Balance 25,638 Row 2 · 2026-10-01 · Exercise / conversion · Acquired 1,360 · Balance 26,998 Row 3 · 2026-10-01 · Tax withholding · Disposed 2,098 · Balance 24,900 F1: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 10,637 |
Reported balance
After 2026-10-01 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2026-10-01 · Exercise / conversion · Disposed 2,659 · Balance 10,637 F2: This represents a restricted stock unit award granted on November 8, 2024 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2025 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter. F3: Not applicable for Restricted Stock Units. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 8,162 |
Reported balance
After 2026-10-01 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2026-10-01 · Exercise / conversion · Disposed 1,360 · Balance 8,162 F4: This represents a restricted stock unit award granted on March 12, 2025 that vests over a three-year period. 33% of the shares subject to such award vested on April 1, 2026 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter. F3: Not applicable for Restricted Stock Units. |
Filing footnotes · ownership attribution and instrument terms
F1: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.
F2: This represents a restricted stock unit award granted on November 8, 2024 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2025 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.
F3: Not applicable for Restricted Stock Units.
F4: This represents a restricted stock unit award granted on March 12, 2025 that vests over a three-year period. 33% of the shares subject to such award vested on April 1, 2026 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.
LiveRamp Holdings, Inc.
Report date September 14, 2017 · Filed September 15, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, $.10 Par ValueSEC Table I · non-derivative | Direct | 62,146 |
Reported balance
After 2017-09-14 transaction · row 1
1 source rowRow 1 · 2017-09-14 · Tax withholding · Disposed 681 · Balance 62,146 F1: These shares were withheld by Acxiom Corporation to satisfy the reporting person's tax obligations that arose on September 14, 2017, when restricted stock units belonging to the reporting person vested. |
| Common Stock, $.10 Par ValueSEC Table I · non-derivative | Indirectby Managed Account 1 | 364.936 |
Reported balance
Holding disclosure · report date 2017-09-14 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 364.936 |
Filing footnotes · ownership attribution and instrument terms
F1: These shares were withheld by Acxiom Corporation to satisfy the reporting person's tax obligations that arose on September 14, 2017, when restricted stock units belonging to the reporting person vested.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 01, 2025 Filed Dec 4, 2025 02:30 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 35,000 | $20.14 | $704,900.00 |
DisclosureSEC source: 0001652956-25-000005 · wk-form4_1764815418.xml · nonDerivative · entry 1 Monroe Terilyn J. · CIK 0001652956 · Chief People Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 61,087 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 01, 2025 Filed Oct 3, 2025 00:05 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 10,477 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001652956-25-000003 · wk-form4_1759449950.xml · derivative · entry 3 Monroe Terilyn J. · CIK 0001652956 · Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,274 Underlying: Common Stock · 10,477 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This represents a restricted stock unit award granted on November 8, 2024 that vests over a three-year period. 33% of the shares subject to such award vests on October 1, 2025 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| October 01, 2025 Filed Oct 3, 2025 00:05 UTC | Guardant Health, Inc. GH · Entity 3238 | Tax withholdingCommon Stock | 5,310 | $62.65 | $332,671.50 |
DisclosureSEC source: 0001652956-25-000003 · wk-form4_1759449950.xml · nonDerivative · entry 2 Monroe Terilyn J. · CIK 0001652956 · Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,087 F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. Read SEC document |
| October 01, 2025 Filed Oct 3, 2025 00:05 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 10,477 | $0.00 | $0.00 |
DisclosureSEC source: 0001652956-25-000003 · wk-form4_1759449950.xml · nonDerivative · entry 1 Monroe Terilyn J. · CIK 0001652956 · Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,397 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 12, 2025 Filed Mar 13, 2025 20:43 UTC | Guardant Health, Inc. GH · Entity 3238 | GrantRestricted Stock Units · Derivative | 16,242 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-25-000078 · wk-form4_1741898591.xml · derivative · entry 2 Monroe Terilyn J. · CIK 0001652956 · Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,242 Underlying: Common Stock · 16,242 shares Expires not disclosed F2 · derivative.exercise_date: This represents a restricted stock unit award granted on March 12, 2025 that vests over a three-year period. 33% of the shares subject to such award vests on April 1, 2026, and the remaining 67% of the shares vest in equal quarterly installments over the remaining two-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| March 12, 2025 Filed Mar 13, 2025 20:43 UTC | Guardant Health, Inc. GH · Entity 3238 | GrantStock Option (Right to Buy) · Derivative | 24,363 | $0.00 Strike: $43.10 | $0.00 |
DisclosureSEC source: 0001576280-25-000078 · wk-form4_1741898591.xml · derivative · entry 1 Monroe Terilyn J. · CIK 0001652956 · Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,363 Underlying: Common Stock · 24,363 shares Expires 2035-03-12 F1 · derivative.exercise_date: This represents a stock option award granted on March 12, 2025 that vests over a three-year period. 33% of the shares subject to such award vests on April 1, 2026, and the remaining 67% of the shares vests in equal monthly installments over the remaining two-year period thereafter. Read SEC document |
| March 01, 2025 Filed Mar 4, 2025 23:15 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionPerformance-Based Restricted Stock Units · Derivative | 14,894 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-25-000060 · wk-form4_1741130096.xml · derivative · entry 4 Monroe Terilyn J. · CIK 0001652956 · Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,794 Underlying: Common Stock · 14,894 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This represents a performance-based restricted stock unit award granted on February 26, 2024, that a performance metric was achieved and that 33% of the shares subject to such award vested on March 1, 2025. The remaining 67% of the shares vest over the following two years, with 33% of the shares subject to the award vesting on January 1, 2026, and 34% of the shares subject to the award vesting on January 1, 2027. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| March 01, 2025 Filed Mar 4, 2025 23:15 UTC | Guardant Health, Inc. GH · Entity 3238 | Tax withholdingCommon Stock | 6,565 | $42.55 | $279,340.75 |
DisclosureSEC source: 0001576280-25-000060 · wk-form4_1741130096.xml · nonDerivative · entry 2 Monroe Terilyn J. · CIK 0001652956 · Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,257 F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. Read SEC document |
| March 01, 2025 Filed Mar 4, 2025 23:15 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 14,894 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-25-000060 · wk-form4_1741130096.xml · nonDerivative · entry 1 Monroe Terilyn J. · CIK 0001652956 · Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,822 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 15, 2025 Filed Jan 16, 2025 22:04 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 17,378 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-25-000024 · wk-form4_1737065062.xml · derivative · entry 3 Monroe Terilyn J. · CIK 0001652956 · Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,758 Underlying: Common Stock · 17,378 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This represents a restricted stock unit award granted on February 26, 2024 that vests over a three-year period. 33% of the shares subject to such award vests on the one-year anniversary of January 15, 2024 and the remaining 67% of the shares vests annually over the remaining two-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| January 15, 2025 Filed Jan 16, 2025 22:04 UTC | Guardant Health, Inc. GH · Entity 3238 | Tax withholdingCommon Stock | 6,420 | $37.50 | $240,750.00 |
DisclosureSEC source: 0001576280-25-000024 · wk-form4_1737065062.xml · nonDerivative · entry 2 Monroe Terilyn J. · CIK 0001652956 · Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,928 F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. Read SEC document |
| January 15, 2025 Filed Jan 16, 2025 22:04 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 17,378 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-25-000024 · wk-form4_1737065062.xml · nonDerivative · entry 1 Monroe Terilyn J. · CIK 0001652956 · Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,348 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 08, 2024 Filed Nov 12, 2024 23:15 UTC | Guardant Health, Inc. GH · Entity 3238 | GrantRestricted Stock Units · Derivative | 31,751 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000275 · wk-form4_1731453324.xml · derivative · entry 2 Monroe Terilyn J. · CIK 0001652956 · Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,751 Underlying: Common Stock · 31,751 shares Expires not disclosed F2 · derivative.exercise_date: This represents a restricted stock unit award granted on November 8, 2024 that vests over a three-year period. 33% of the shares subject to such award vests on October 1, 2025 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| November 08, 2024 Filed Nov 12, 2024 23:15 UTC | Guardant Health, Inc. GH · Entity 3238 | GrantStock Option (Right to Buy) · Derivative | 47,627 | $0.00 Strike: $28.61 | $0.00 |
DisclosureSEC source: 0001576280-24-000275 · wk-form4_1731453324.xml · derivative · entry 1 Monroe Terilyn J. · CIK 0001652956 · Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,627 Underlying: Common Stock · 47,627 shares Expires 2034-11-08 F1 · derivative.exercise_date: This represents a stock option award granted on November 8, 2024 that vests over a three-year period. 33% of the shares subject to such award vests on October 1, 2025, and the remaining 67% of the shares vests in equal monthly installments over the remaining two-year period thereafter. Read SEC document |
| February 26, 2024 Filed Feb 28, 2024 00:07 UTC | Guardant Health, Inc. GH · Entity 3238 | GrantRestricted Stock Units · Derivative | 52,136 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000045 · wk-form4_1709078837.xml · derivative · entry 2 Monroe Terilyn J. · CIK 0001652956 · Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,136 Underlying: Common Stock · 52,136 shares Expires not disclosed F2 · derivative.exercise_date: This represents a restricted stock unit award granted on February 26, 2024 that vests over a three-year period. 33% of the shares subject to such award will vest on the one-year anniversary of January 15, 2024 and the remaining 67% of the shares vests annually over the remaining two-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| February 26, 2024 Filed Feb 28, 2024 00:07 UTC | Guardant Health, Inc. GH · Entity 3238 | GrantStock Option (Right to Buy) · Derivative | 78,204 | $0.00 Strike: $20.14 | $0.00 |
DisclosureSEC source: 0001576280-24-000045 · wk-form4_1709078837.xml · derivative · entry 1 Monroe Terilyn J. · CIK 0001652956 · Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 78,204 Underlying: Common Stock · 78,204 shares Expires 2034-02-26 F1 · derivative.exercise_date: This represents a stock option granted on February 26, 2024 that vests over a three-year period. 33% of the shares subject to such award will vest on the one-year anniversary of January 2, 2024 and the remaining 67% of the shares vests in equal monthly installments over the remaining two-year period thereafter. Read SEC document |
| September 14, 2017 Filed Sep 15, 2017 15:49 UTC | LiveRamp Holdings, Inc. ACXM · Entity 4412 | Tax withholdingCommon Stock, $.10 Par Value | 681 | $23.63 | $16,092.03 |
DisclosureSEC source: 0001652956-17-000007 · edgardoc.xml · nonDerivative · entry 1 Monroe Terilyn J. · CIK 0001652956 · Chief People & Culture Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,146 F1 · shares: These shares were withheld by Acxiom Corporation to satisfy the reporting person's tax obligations that arose on September 14, 2017, when restricted stock units belonging to the reporting person vested. Read SEC document |
| June 12, 2017 Filed Jun 14, 2017 22:13 UTC | LiveRamp Holdings, Inc. ACXM · Entity 4412 | GrantCommon Stock, $.10 Par Value | 10,437 | $0.00 | $0.00 |
DisclosureSEC source: 0001652956-17-000006 · edgardoc.xml · nonDerivative · entry 2 Monroe Terilyn J. · CIK 0001652956 · Chief People & Culture Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,827 F2 · shares: This is a grant of performance units (PSUs). Vesting will occur subsequent to the determination of attainment of certain performance criteria approved by the Compensation Committee of the registrant's Board of Directors for the performance period ending March 31, 2020, contingent upon the reporting person's continued employment with the registrant. Attainment may be determined by the Compensation Committee to be in a range of 0 to 200% of the amount of PSUs granted. Read SEC document |
| June 12, 2017 Filed Jun 14, 2017 22:13 UTC | LiveRamp Holdings, Inc. ACXM · Entity 4412 | GrantCommon Stock, $.10 Par Value | 10,437 | $0.00 | $0.00 |
DisclosureSEC source: 0001652956-17-000006 · edgardoc.xml · nonDerivative · entry 1 Monroe Terilyn J. · CIK 0001652956 · Chief People & Culture Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,390 F1 · shares: This is a grant of restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of the registrant's common stock. Vesting will begin one year from May 23, 2017, with 1/4 of the total becoming vested on that date and 1/16 quarterly thereafter until 100% vested, contingent upon the reporting person's continued employment with the registrant. Read SEC document |
| May 24, 2017 Filed May 25, 2017 23:01 UTC | LiveRamp Holdings, Inc. ACXM · Entity 4412 | Tax withholdingCommon Stock, $.10 Par Value | 1,261 | $25.85 | $32,596.85 |
DisclosureSEC source: 0001652956-17-000004 · edgardoc.xml · nonDerivative · entry 1 Monroe Terilyn J. · CIK 0001652956 · Chief People & Culture Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,953 F1 · shares: These shares were withheld by Acxiom Corporation to satisfy the reporting person's tax obligations that arose on May 24, 2017, when restricted stock units belonging to the reporting person vested. Read SEC document |
| March 31, 2017 Filed Apr 21, 2017 22:19 UTC | LiveRamp Holdings, Inc. ACXM · Entity 4412 | OtherCommon Stock, $.10 Par Value | 9 | $24.20 | $217.80 |
DisclosureSEC source: 0001652956-17-000002 · edgardoc.xml · nonDerivative · entry 9 Monroe Terilyn J. · CIK 0001652956 · Chief People & Culture Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,214 F1 · shares: These shares were acquired through participation in the Company's 16b-3 qualified Employee Stock Purchase Plan. Read SEC document |
| March 31, 2017 Filed May 3, 2017 18:43 UTC Amendment | LiveRamp Holdings, Inc. ACXM · Entity 4412 | OtherCommon Stock, $.10 Par Value | 364.936 | $0.00 | $0.00 |
DisclosureSEC source: 0001652956-17-000003 · edgardoc.xml · nonDerivative · entry 10 Monroe Terilyn J. · CIK 0001652956 · Chief People & Culture Officer 10b5-1 filing: Not disclosed Ownership: Indirect · by Managed Account 1 Disclosed balance after: 364.936 F2 · shares: These shares were acquired during fiscal 2017 under the Company's 401(k) Retirement Savings Plan. Read SEC document |
| March 31, 2017 Filed May 3, 2017 18:43 UTC Amendment | LiveRamp Holdings, Inc. ACXM · Entity 4412 | OtherCommon Stock, $.10 Par Value | 9 | $24.20 | $217.80 |
DisclosureSEC source: 0001652956-17-000003 · edgardoc.xml · nonDerivative · entry 9 Monroe Terilyn J. · CIK 0001652956 · Chief People & Culture Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,214 F1 · shares: These shares were acquired through participation in the Company's 16b-3 qualified Employee Stock Purchase Plan. Read SEC document |
| February 28, 2017 Filed Apr 21, 2017 22:19 UTC | LiveRamp Holdings, Inc. ACXM · Entity 4412 | OtherCommon Stock, $.10 Par Value | 8 | $24.24 | $193.94 |
DisclosureSEC source: 0001652956-17-000002 · edgardoc.xml · nonDerivative · entry 8 Monroe Terilyn J. · CIK 0001652956 · Chief People & Culture Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,205 F1 · shares: These shares were acquired through participation in the Company's 16b-3 qualified Employee Stock Purchase Plan. Read SEC document |
| February 28, 2017 Filed May 3, 2017 18:43 UTC Amendment | LiveRamp Holdings, Inc. ACXM · Entity 4412 | OtherCommon Stock, $.10 Par Value | 8 | $24.24 | $193.94 |
DisclosureSEC source: 0001652956-17-000003 · edgardoc.xml · nonDerivative · entry 8 Monroe Terilyn J. · CIK 0001652956 · Chief People & Culture Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,205 F1 · shares: These shares were acquired through participation in the Company's 16b-3 qualified Employee Stock Purchase Plan. Read SEC document |
| January 31, 2017 Filed Apr 21, 2017 22:19 UTC | LiveRamp Holdings, Inc. ACXM · Entity 4412 | OtherCommon Stock, $.10 Par Value | 9 | $22.19 | $199.67 |
DisclosureSEC source: 0001652956-17-000002 · edgardoc.xml · nonDerivative · entry 7 Monroe Terilyn J. · CIK 0001652956 · Chief People & Culture Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,197 F1 · shares: These shares were acquired through participation in the Company's 16b-3 qualified Employee Stock Purchase Plan. Read SEC document |
| January 31, 2017 Filed May 3, 2017 18:43 UTC Amendment | LiveRamp Holdings, Inc. ACXM · Entity 4412 | OtherCommon Stock, $.10 Par Value | 9 | $22.19 | $199.67 |
DisclosureSEC source: 0001652956-17-000003 · edgardoc.xml · nonDerivative · entry 7 Monroe Terilyn J. · CIK 0001652956 · Chief People & Culture Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,197 F1 · shares: These shares were acquired through participation in the Company's 16b-3 qualified Employee Stock Purchase Plan. Read SEC document |
| January 03, 2017 Filed Apr 21, 2017 22:19 UTC | LiveRamp Holdings, Inc. ACXM · Entity 4412 | OtherCommon Stock, $.10 Par Value | 9 | $22.49 | $202.42 |
DisclosureSEC source: 0001652956-17-000002 · edgardoc.xml · nonDerivative · entry 6 Monroe Terilyn J. · CIK 0001652956 · Chief People & Culture Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,188 F1 · shares: These shares were acquired through participation in the Company's 16b-3 qualified Employee Stock Purchase Plan. Read SEC document |
| January 03, 2017 Filed May 3, 2017 18:43 UTC Amendment | LiveRamp Holdings, Inc. ACXM · Entity 4412 | OtherCommon Stock, $.10 Par Value | 9 | $22.49 | $202.42 |
DisclosureSEC source: 0001652956-17-000003 · edgardoc.xml · nonDerivative · entry 6 Monroe Terilyn J. · CIK 0001652956 · Chief People & Culture Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,188 F1 · shares: These shares were acquired through participation in the Company's 16b-3 qualified Employee Stock Purchase Plan. Read SEC document |
| November 30, 2016 Filed Apr 21, 2017 22:19 UTC | LiveRamp Holdings, Inc. ACXM · Entity 4412 | OtherCommon Stock, $.10 Par Value | 9 | $22.55 | $202.95 |
DisclosureSEC source: 0001652956-17-000002 · edgardoc.xml · nonDerivative · entry 5 Monroe Terilyn J. · CIK 0001652956 · Chief People & Culture Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,179 F1 · shares: These shares were acquired through participation in the Company's 16b-3 qualified Employee Stock Purchase Plan. Read SEC document |
| November 30, 2016 Filed May 3, 2017 18:43 UTC Amendment | LiveRamp Holdings, Inc. ACXM · Entity 4412 | OtherCommon Stock, $.10 Par Value | 9 | $22.55 | $202.95 |
DisclosureSEC source: 0001652956-17-000003 · edgardoc.xml · nonDerivative · entry 5 Monroe Terilyn J. · CIK 0001652956 · Chief People & Culture Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,179 F1 · shares: These shares were acquired through participation in the Company's 16b-3 qualified Employee Stock Purchase Plan. Read SEC document |
| October 31, 2016 Filed Apr 21, 2017 22:19 UTC | LiveRamp Holdings, Inc. ACXM · Entity 4412 | OtherCommon Stock, $.10 Par Value | 9 | $20.03 | $180.23 |
DisclosureSEC source: 0001652956-17-000002 · edgardoc.xml · nonDerivative · entry 4 Monroe Terilyn J. · CIK 0001652956 · Chief People & Culture Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,170 F1 · shares: These shares were acquired through participation in the Company's 16b-3 qualified Employee Stock Purchase Plan. Read SEC document |
| October 31, 2016 Filed May 3, 2017 18:43 UTC Amendment | LiveRamp Holdings, Inc. ACXM · Entity 4412 | OtherCommon Stock, $.10 Par Value | 9 | $20.03 | $180.23 |
DisclosureSEC source: 0001652956-17-000003 · edgardoc.xml · nonDerivative · entry 4 Monroe Terilyn J. · CIK 0001652956 · Chief People & Culture Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,170 F1 · shares: These shares were acquired through participation in the Company's 16b-3 qualified Employee Stock Purchase Plan. Read SEC document |
| September 30, 2016 Filed Apr 21, 2017 22:19 UTC | LiveRamp Holdings, Inc. ACXM · Entity 4412 | OtherCommon Stock, $.10 Par Value | 9 | $22.65 | $203.87 |
DisclosureSEC source: 0001652956-17-000002 · edgardoc.xml · nonDerivative · entry 3 Monroe Terilyn J. · CIK 0001652956 · Chief People & Culture Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,161 F1 · shares: These shares were acquired through participation in the Company's 16b-3 qualified Employee Stock Purchase Plan. Read SEC document |
| September 30, 2016 Filed May 3, 2017 18:43 UTC Amendment | LiveRamp Holdings, Inc. ACXM · Entity 4412 | OtherCommon Stock, $.10 Par Value | 9 | $22.65 | $203.87 |
DisclosureSEC source: 0001652956-17-000003 · edgardoc.xml · nonDerivative · entry 3 Monroe Terilyn J. · CIK 0001652956 · Chief People & Culture Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,161 F1 · shares: These shares were acquired through participation in the Company's 16b-3 qualified Employee Stock Purchase Plan. Read SEC document |
| September 14, 2016 Filed Sep 15, 2016 16:36 UTC | LiveRamp Holdings, Inc. ACXM · Entity 4412 | Tax withholdingCommon Stock, $.10 Par Value | 681 | $25.74 | $17,528.94 |
DisclosureSEC source: 0001652956-16-000010 · edgardoc.xml · nonDerivative · entry 1 Monroe Terilyn J. · CIK 0001652956 · Chief People & Culture Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,133 F1 · shares: These shares were withheld by Acxiom Corporation to satisfy the reporting person's tax obligations that arose on September 14, 2016, when restricted stock units belonging to the reporting person vested. Read SEC document |
| August 31, 2016 Filed Apr 21, 2017 22:19 UTC | LiveRamp Holdings, Inc. ACXM · Entity 4412 | OtherCommon Stock, $.10 Par Value | 9 | $22.09 | $198.82 |
DisclosureSEC source: 0001652956-17-000002 · edgardoc.xml · nonDerivative · entry 2 Monroe Terilyn J. · CIK 0001652956 · Chief People & Culture Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,833 F1 · shares: These shares were acquired through participation in the Company's 16b-3 qualified Employee Stock Purchase Plan. Read SEC document |
| August 31, 2016 Filed May 3, 2017 18:43 UTC Amendment | LiveRamp Holdings, Inc. ACXM · Entity 4412 | OtherCommon Stock, $.10 Par Value | 9 | $22.09 | $198.82 |
DisclosureSEC source: 0001652956-17-000003 · edgardoc.xml · nonDerivative · entry 2 Monroe Terilyn J. · CIK 0001652956 · Chief People & Culture Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,833 F1 · shares: These shares were acquired through participation in the Company's 16b-3 qualified Employee Stock Purchase Plan. Read SEC document |
| August 01, 2016 Filed Apr 21, 2017 22:19 UTC | LiveRamp Holdings, Inc. ACXM · Entity 4412 | OtherCommon Stock, $.10 Par Value | 10 | $19.72 | $197.20 |
DisclosureSEC source: 0001652956-17-000002 · edgardoc.xml · nonDerivative · entry 1 Monroe Terilyn J. · CIK 0001652956 · Chief People & Culture Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,824 F1 · shares: These shares were acquired through participation in the Company's 16b-3 qualified Employee Stock Purchase Plan. Read SEC document |
| August 01, 2016 Filed May 3, 2017 18:43 UTC Amendment | LiveRamp Holdings, Inc. ACXM · Entity 4412 | OtherCommon Stock, $.10 Par Value | 10 | $19.72 | $197.20 |
DisclosureSEC source: 0001652956-17-000003 · edgardoc.xml · nonDerivative · entry 1 Monroe Terilyn J. · CIK 0001652956 · Chief People & Culture Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,824 F1 · shares: These shares were acquired through participation in the Company's 16b-3 qualified Employee Stock Purchase Plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.